REX American Resources reported lower profitability in Q2 2025 due to decreased dried distiller grains pricing and higher shipping costs, despite volume growth in ethanol and co-product markets. The company remains optimistic about future performance, supported by favorable corn supply trends, rising ethanol exports, and recent legislative tax credit extensions.

REX American Resources reported Q2 2025 net income of $7.1 million, a 43% year-over-year decline. The company announced a two-for-one stock split, advanced its ethanol capacity expansion, and made progress on carbon capture projects amid supportive legislative changes.

REX (REX) delivered earnings and revenue surprises of 87.10% and 15.17%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Seadrill (SDRL) delivered earnings and revenue surprises of 19.12% and 0.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Aemetis (AMTX) delivered earnings and revenue surprises of -34.88% and 7.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers. Ontrak, Inc. (NASDAQ: OTRK) gained 55% to $0.9239. Binah Capital Group, Inc. (NASDAQ: BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Allego N.V. (NASDAQ: ALLG) rose 32.8% to $1.7650. Akanda Corp. (NASDAQ: AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Destiny Tech100 Inc. (NASDAQ: DXYZ) rose 26% to $22.15. REX American Resources Corporation (NYSE: REX) gained 23.2% to $54.15 following upbeat earnings. Nutriband Inc. (NASDAQ: NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Summit Therapeutics Inc. (NASDAQ: ...

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions. On Wednesday, Fed Governor Christopher J. Waller spoke in opposition to an early interest rate cut, citing the still uncertain inflation path, and noted that his stance is shared by a robust share of the Fed board. Thursday saw an upward revision to the fourth-quarter U.S. gross domestic product, with the economy expanding by 3.4% on an annualized basis, exceeding the previously estimated 3.2%. Traders marginally scaled back their bets on a June rate cut scenario, now placing the likelihood at 64%, down from 70% on Wednesday, according to the CME Group’s FedWatch tool. While the S&P 500 and the Dow remained unchanged for the day, the Nasdaq 100 eased by 0.2%, influenced by reduced rate cut expectations and increasing commodity prices that weighed on tech companies. Gold surged to $2,225 per ounce intraday ...Full story available on Benzinga.com

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat quarterly earnings. REX American Resources posted quarterly GAAP earnings of $1.16 per share, versus market estimates of 68 cents per share, according to data from Benzinga Pro. REX American Resources shares jumped 23.2% to $54.15 on Thursday. Here are some other big stocks recording gains in today’s session. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares gained 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Hut 8 ...

REX (REX) delivered earnings and revenue surprises of 63.38% and 10.36%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?

Aemetis (AMTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Vaalco Energy (EGY) delivered earnings and revenue surprises of 146.67% and 14.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

REX American Resources, Dillard's, Post Holdings and Griffon are part of the Zacks Screen of the Week article.